The study focuses on admixture mapping, a statistical approach developed for populations whose genomes contain ancestry segments inherited from multiple continental or regional source populations. In an admixed individual, nearby stretches of DNA can have different ancestral origins. For example, one chromosome segment may be more closely related to West African reference populations, while another may reflect European, Indigenous American or East Asian ancestry. By estimating the ancestry of these local genomic segments and testing whether they are associated with a trait, researchers can search for genetic regions that help explain phenotypic variation. This differs from conventional genome-wide association studies, which generally test individual genetic variants across a population.

The distinction is important because a person’s overall or “global” ancestry may conceal the influence of particular genomic regions. Two people can have broadly similar ancestry proportions but carry different local ancestry patterns across their chromosomes. Admixture mapping takes advantage of this mosaic structure. If a trait is consistently associated with a particular ancestry at one genomic location, that signal may point to genetic variants, regulatory elements or biological pathways that influence the phenotype. However, local ancestry is not itself a biological cause. It is a marker for inherited genetic variation, and its interpretation requires careful attention to environmental exposures, socioeconomic conditions, access to health care and the historical forces that shaped population structure.

The All of Us Research Program provides an unusually broad setting for this kind of analysis. The program was created to assemble health, genomic, demographic, lifestyle and electronic medical-record data from a highly diverse group of participants in the United States. Rather than relying primarily on cohorts recruited for a single disease, All of Us is designed to support research across many conditions and traits. Its participants contribute information through surveys, clinical records, physical measurements and, for many, genomic testing. This combination allows investigators to study ancestry-related patterns alongside the social and medical context in which those patterns occur.

Mandla and colleagues use this resource to improve the resolution of comparisons between populations with different ancestral histories. Such comparisons have often been limited by the underrepresentation of non-European groups in genetic studies, uneven sample sizes and analytical methods that treat ancestry as a single genome-wide percentage. Those limitations can produce unstable associations or make biological differences appear larger or smaller than they really are. By incorporating local ancestry and a much larger, more heterogeneous dataset, the researchers can test whether observed phenotypic differences are linked to particular genomic regions rather than to broad labels assigned to entire populations.

The technical challenge is substantial. Before an admixture-mapping analysis can begin, scientists must infer local ancestry along each participant’s chromosomes. This typically involves comparing genetic markers with reference panels representing ancestral source populations and calculating the most likely ancestry state for successive genomic segments. The resulting data are then analyzed alongside traits such as disease risk, physiological measurements or other characteristics recorded in health records. Statistical models must account for relatedness among participants, sex, age, study site, global ancestry and other potential confounders. The goal is to identify ancestry-associated signals that remain meaningful after these factors are considered.

A major contribution of the work is its emphasis on improving the characterization of cross-population phenotypic differences rather than simply ranking groups by genetic risk. Population-level differences in a trait can arise through multiple pathways. They may reflect genetic variation, differences in diet or occupational exposure, unequal treatment within health systems, environmental pollution, stress, income, neighborhood conditions or historical patterns of migration. In many cases, these factors are correlated with ancestry, making them difficult to disentangle. Admixture mapping cannot solve that problem alone, but it can help identify genomic regions that warrant functional investigation while reducing the temptation to interpret every population difference as either purely genetic or purely social.

The findings also carry implications for precision medicine. Many genetic prediction models perform best in populations whose genomic data were used to build them, but less accurately in groups that have been historically excluded from research. This imbalance can affect disease-risk estimation, drug-response prediction and the interpretation of clinical genetic tests. A more detailed understanding of local ancestry may help researchers determine whether a genetic association operates similarly across populations or whether its effect changes depending on the surrounding genomic background. It may also reveal variants that were missed in earlier studies because they are uncommon in European-ancestry datasets but more frequent in other populations.

At the same time, the study underscores why ancestry-aware genomics must be communicated carefully. Genetic ancestry is not equivalent to race, ethnicity, nationality or culture, and no population is genetically uniform. Admixed genomes are shaped by many generations of movement and reproduction, while racial categories are social classifications that vary across time and place. The researchers’ approach is therefore most useful when it points toward specific biological mechanisms and is interpreted alongside detailed information about participants’ lived environments. Used responsibly, large-scale admixture mapping can expand the reach of genomic medicine without turning population labels into biological destiny.

The broader message from the All of Us analysis is that diversity is not merely a matter of representation or fairness, although both remain essential. It is also a scientific resource that can expose genetic signals, environmental interactions and disease mechanisms that would remain invisible in narrower datasets. By combining local ancestry inference with extensive health information, the study provides a framework for examining how inherited variation and social context intersect in real populations. The result is a more precise, more cautious and potentially more clinically useful picture of human phenotypic diversity—one that replaces simplistic population comparisons with a detailed view of the genomic mosaic carried by each individual.

Subject of Research: Large-scale admixture mapping, local genetic ancestry, and cross-population phenotypic differences using data from the All of Us Research Program.

Article Title: Large-scale admixture mapping in the All of Us Research Program improves the characterization of cross-population phenotypic differences.

Article References: Mandla, R., Shi, Z., Hou, K. et al. “Large-scale admixture mapping in the All of Us Research Program improves the characterization of cross-population phenotypic differences.” Nature Communications (2026). https://doi.org/10.1038/s41467-026-75515-6

Image Credits: AI Generated

DOI: 10.1038/s41467-026-75515-6

Keywords: admixture mapping, local ancestry, genetic ancestry, population genomics, All of Us Research Program, phenotypic diversity, precision medicine, human genetics, genomic medicine, cross-population differences

Human metabolism, the complex network of biochemical reactions that sustain life, exhibits remarkable variability among individuals. However, parsing out the precise genetic contributions to this variability has remained a formidable challenge for scientists. This new study harnessed extensive genetic and metabolomic datasets from the UK Biobank, examining over half a million participants. By analyzing the blood levels of 250 distinct metabolites—including vital lipid molecules and amino acids—the researchers have systematically delineated the genetic factors that shape metabolic diversity.

The scale and scope of this analysis are unparalleled. The consortium, spearheaded by experts at the Berlin Institute of Health @ Charité (BIH) and Queen Mary University of London, integrated large-scale genetic data encompassing individuals of European, African, and Asian descent residing in the UK. This multi-ancestry approach allowed the scientists to ascertain that genetic control of metabolites is remarkably conserved across diverse populations and between sexes, suggesting that the findings have broad biological relevance and are applicable to populations worldwide.

One of the study’s remarkable achievements is the identification of genes previously unassociated with metabolic pathways. These discoveries deepen our understanding of human metabolism, highlighting intricate genetic networks and interactions previously hidden in genetic studies limited by smaller sample sizes or single ancestral backgrounds. Such insights not only enrich fundamental biological knowledge but also open new avenues for clinical and therapeutic research.

Beyond mapping genetic determinants of typical metabolic variation, the study elucidated how certain genes regulating blood metabolite levels also predispose individuals to complex diseases. This overlap between metabolic regulation and disease susceptibility underscores the clinical importance of metabolic traits as biomarkers or targets in disease prevention and treatment strategies. For instance, the researchers identified the gene VEGFA as a novel regulator of high-density lipoprotein (HDL) cholesterol, often dubbed the “good cholesterol.” As HDL has a protective role against cardiovascular disease, VEGFA emerges as a promising target for drug development aimed at cardiovascular risk reduction.

The remarkable depth of this analysis was enabled by biobanks—massive repositories of genetic, phenotypic, and health-related data. The UK Biobank stands as a paragon in this field, having recruited a diverse cohort of 500,000 people and combining their genetic profiles with extensive health and lifestyle information. Utilizing this unprecedented dataset, the researchers conducted a highly powered and systematic investigation, maximizing statistical robustness and ensuring broad generalizability of the findings.

While genetics clearly play a pivotal role in metabolic individuality, the authors emphasize the indispensable influence of modifiable environmental factors such as diet, physical activity, and lifestyle choices. These elements dynamically interact with genetic predispositions to shape metabolism, underscoring the holistic complexity of metabolic health. This nuanced understanding reinforces the need for integrative approaches in managing health and disease, balancing genetic insights with personalized lifestyle interventions.

Lead author Dr. Martijn Zoodsma, a postdoctoral researcher at the BIH in Berlin, articulated the transformative potential of this work: “Mapping the genetic regulation of hundreds of blood metabolites at this scale is a landmark achievement that provides a comprehensive reference framework. It equips the scientific community with powerful tools to unravel disease risk mechanisms and decode the genetic architecture underlying metabolic diversity.” His assertion highlights the study’s foundational role in driving forward the field of metabolic genetics.

Senior author Professor Maik Pietzner, an expert in Health Data Modelling affiliated with both BIH and Queen Mary University’s Precision Health University Research Institute (PHURI), contextualized the findings within public health priorities. “Despite advances in lipid-lowering therapies, such as statins, heart disease persists as a leading cause of mortality. Our genetic mapping identifies novel molecular pathways that could inspire innovative therapeutics, aiming to reduce cardiovascular fatalities further by targeting metabolic regulation more precisely.”

The study also exemplifies the power of collaborative academic and industrial partnerships. Senior author Professor Claudia Langenberg, director of PHURI and head of Computational Medicine at the BIH, lauded the integration of Nightingale Health’s metabolomic technology, which enabled precise quantification of lipid and metabolite profiles in the entire UK Biobank cohort. Professor Langenberg remarked, “Such large-scale technology deployment is essential to capture rare genetic variations and to reveal the fundamental commonalities in metabolic control across ancestries and sexes—reminding us that despite our diversity, we share core biological processes.”

This research propels the field towards a future where tailored metabolic profiling and genetic risk assessment converge to foster personalized prevention and treatment strategies. By illuminating the genetic landscape governing metabolites tied to health and disease, this study not only broadens scientific horizons but also holds promise for transformative impacts on global health.

As metabolomics and genomics continue to intertwine, the vast treasure trove of data offered by biobanks worldwide will fuel deeper explorations into how our genetic code influences metabolism. This work sets a precedent and benchmark for such investigations, pushing the boundaries of what we understand about human biology and offering hope for more effective interventions tailored to individual metabolic profiles.

The implications of this study extend beyond heart disease. Metabolic dysregulation underpins a wide array of conditions—from diabetes and neurodegenerative disorders to cancer and aging. Decoding the genetic architecture of metabolism thus promises ripple effects across medicine, enabling insights into disease mechanisms and the development of novel biomarkers and therapeutics.

In closing, this landmark genetic map of human metabolism exemplifies the confluence of big data science, cutting-edge technology, and international collaboration. It demonstrates how leveraging vast, diverse datasets can unravel the intricate genetic influences shaping our biological individuality, setting the stage for a new era in precision health and personalized medicine.

Subject of Research: People
Article Title: A genetic map of human metabolism across the allele frequency spectrum
News Publication Date: 3-Oct-2025
Web References: DOI link
Keywords: DNA, Genetic testing, Genetic methods